Becton Dickinson ROE 2010-2024 | BDX

Current and historical return on equity (ROE) values for Becton Dickinson (BDX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Becton Dickinson ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-06-30 $1.41B $25.87B 5.51%
2024-03-31 $1.32B $25.65B 5.13%
2023-12-31 $1.22B $25.33B 4.75%
2023-09-30 $1.42B $25.80B 5.54%
2023-06-30 $1.58B $25.94B 6.18%
2023-03-31 $1.53B $25.69B 5.99%
2022-12-31 $1.52B $25.47B 6.03%
2022-09-30 $1.69B $25.28B 6.79%
2022-06-30 $1.67B $25.49B 6.81%
2022-03-31 $1.83B $24.53B 7.59%
2021-12-31 $1.68B $24.16B 6.93%
2021-09-30 $2.00B $23.68B 8.23%
2021-06-30 $1.87B $24.14B 7.66%
2021-03-31 $1.64B $24.83B 6.74%
2020-12-31 $1.51B $24.66B 6.46%
2020-09-30 $0.77B $23.77B 3.41%
2020-06-30 $0.79B $24.02B 3.61%
2020-03-31 $0.92B $20.95B 4.36%
2019-12-31 $0.76B $21.20B 3.57%
2019-09-30 $1.08B $21.08B 5.07%
2019-06-30 $0.78B $21.50B 3.68%
2019-03-31 $0.93B $21.31B 4.36%
2018-12-31 $0.90B $21.40B 4.22%
2018-09-30 $0.16B $20.99B 0.75%
2018-06-30 $0.62B $21.36B 3.24%
2018-03-31 $-0.10B $21.15B -0.59%
2017-12-31 $0.29B $21.25B 2.15%
2017-09-30 $1.03B $12.95B 10.03%
2017-06-30 $0.76B $12.59B 8.50%
2017-03-31 $1.32B $7.96B 16.85%
2016-12-31 $1.31B $7.58B 16.94%
2016-09-30 $0.98B $7.63B 12.78%
2016-06-30 $1.14B $8.03B 15.13%
2016-03-31 $0.81B $7.67B 11.06%
2015-12-31 $0.69B $7.22B 9.56%
2015-09-30 $0.70B $7.16B 10.43%
2015-06-30 $0.82B $7.25B 13.29%
2015-03-31 $1.08B $7.16B 19.05%
2014-12-31 $1.15B $5.07B 22.10%
2014-09-30 $1.19B $5.05B 22.76%
2014-06-30 $0.97B $5.38B 18.72%
2014-03-31 $0.95B $5.32B 18.86%
2013-12-31 $0.94B $5.08B 19.33%
2013-09-30 $1.29B $5.04B 27.48%
2013-06-30 $1.49B $4.72B 33.32%
2013-03-31 $1.52B $4.59B 34.82%
2012-12-31 $1.53B $4.47B 35.39%
2012-09-30 $1.17B $4.14B 26.63%
2012-06-30 $1.18B $4.24B 25.86%
2012-03-31 $1.20B $4.48B 24.77%
2011-12-31 $1.22B $4.73B 24.42%
2011-09-30 $1.27B $4.83B 25.29%
2011-06-30 $1.37B $5.30B 26.42%
2011-03-31 $1.33B $5.10B 25.91%
2010-12-31 $1.32B $4.88B 25.57%
2010-09-30 $1.32B $5.44B 25.11%
2010-06-30 $1.24B $5.15B 23.91%
2010-03-31 $1.27B $5.15B 24.50%
2009-12-31 $1.24B $5.26B 24.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.388B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95